Form 4: Adaptive Biotechnologies Director Sells Shares

Sentiment:

Insider Transaction (Form 4)


Katey Einterz Owen, a Director of Adaptive Biotechnologies Corp, sold 9,615 shares of common stock on August 26, 2026 for $26.00 per share.

Summary

  • Open-market sale: disposed of 9,615 Common Stock at $26.00 ($249,990) on August 26, 2026; holds 78,639 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $249,990 of stock on the open market.

Insider Transactions

Katey Einterz Owen — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-08-26Open-market saleCommon Stock9,615$26$250.0K78,639

Key Dates

DateDescription
2026-08-26Open-market sale (9,615 shares)

Keywords

insider transaction, Form 4, ADPT, Adaptive Biotechnologies Corp, bearish, Katey Einterz Owen

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.